Biopharma · FDA Approvals · Stock
BCTX Briacell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients…
Catalyst calendar
Dated catalysts for BCTX, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for BCTX, newest first.
Instant stream — events appear as soon as they are filed.
Decision-gradeMaterialNotableMinor
No events yet.
Peers by market cap
Companies in the same sector closest to BCTX in market value.
RNAZTransCode TherapeuticsMarket cap $27.6M · 1 tracked drug · 1 upcoming catalyst
CVMCel-SciMarket cap $24.3M · 1 tracked drug
CRVOCervoMedMarket cap $24.2M · 1 tracked drug · 1 upcoming catalyst
DRIODarioHealthMarket cap $29.4M
MGXMetagenomiMarket cap $29.5M · 1 tracked drug
AARDAardvark TherapeuticsMarket cap $29.8M · 1 tracked drug
MIRAMIRA PharmaceuticalsMarket cap $23.0M · 3 tracked drugs
EYPTEyePointMarket cap $30.0M · 1 tracked drug · 5 upcoming catalysts